文献速递先天性心脏病外科心外重症与机械循环支持

机械循环支持作为成人TGA系统性右心室衰竭患者候选资格的桥接:单中心经验

Mechanical circulatory support as a bridge to candidacy in adults with transposition of the great arteries and a systemic right ventricle.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-11-23

本研究为单中心回顾性研究,纳入2010至2018年间6例接受连续流VAD植入的成人TGA伴系统性右心室衰竭患者。结果显示院内生存率100%,无早期VAD相关并发症,平均随访33个月,4例成功心脏移植,2例仍在等待名单。连续流VAD可作为此类患者桥接候选资格和桥接心脏移植的可行治疗选择。

要点

  • 连续流VAD在成人TGA伴系统性右心室衰竭中可行,院内生存率100%。
  • VAD植入后肺动脉压力和肺血管阻力呈下降趋势,部分患者可过渡至心脏移植。
  • 随访中可见持续性左侧轻瘫1例和非致残性卒中2例,需关注神经系统并发症。

核心结论

  • 连续流VAD治疗是成人TGA伴系统性右心室衰竭患者桥接候选资格和桥接心脏移植的可行治疗选择。

研究设计与样本

  • 单中心回顾性研究,纳入2010至2018年间6例(4男)接受连续流VAD植入的成人TGA伴系统性右心室衰竭患者。
  • 研究终点为全因死亡、主要心脑血管不良事件或泵血栓,随访至心脏移植。

主要发现

  • 平均年龄32±5.7岁,中位INTERMACS级别II(范围1-4),平均肺动脉压48±13 mmHg,平均肺血管阻力5.6±3.5 Wood单位。
  • 术后ICU停留16±9.7天,院内生存率100%,无早期VAD相关并发症。
  • 平均随访33±18个月,持续性左侧轻瘫1例,非致残性卒中2例。
  • VAD植入后平均肺动脉压19±3.4 mmHg(P<0.005),肺血管阻力2.2±0.55 Wood单位(P=0.066)。
  • 4例患者在VAD植入后平均等待30个月后接受心脏移植,2例仍在等待名单(等待时间52和24个月)。

临床怎么用

  • 对于TGA伴系统性右心室衰竭的成人患者,连续流VAD可作为桥接心脏移植候选资格的可行选择。
  • VAD植入后需监测肺动脉压力和肺血管阻力变化,以评估心脏移植候选资格。
  • 随访中应关注神经系统并发症,如卒中或轻瘫。

局限性

  • 本研究为单中心回顾性研究,样本量小(6例),结果需更大规模研究验证。
  • 随访时间有限,长期 outcomes 未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Clinical experience with continuous flow ventricular assist devices (VADs) in patients with transposition of the great arteries (TGA) including dextro-TGA and congenitally corrected TGA is rare, and indications as well as potential benefits or specific hurdles remain unclear. Therefore, our goal was to report on our experience regarding VAD therapy in adult patients with TGA as a bridge to candidacy. METHODS: We performed a single-centre retrospective study of all adult patients with TGA with systemic right ventricular failure who had continuous flow VAD implants between 2010 and 2018. Study end points were all causes of death, major cardiac and cerebrovascular adverse events or pump thrombosis. Follow-up continued until the time of the heart transplant. RESULTS: A total of 6 patients (4 men) had a continuous flow VAD implanted in the context of a failing systemic right ventricle (dextro-TGA after the Mustard procedure: n = 3; congenitally corrected TGA: n = 3). Demographics: mean age 32 ± 5.7 years; median Interagency Registry for Mechanically Assisted Circulatory Support: level II (range 1-4), mean pulmonary artery 48 ± 13 mmHg, mean pulmonary vascular resistance 5.6 ± 3.5 Wood units. Postoperative data: intensive care unit stay: 16 ± 9.7 days; in-hospital survival: 100%; no early VAD-related complications occurred. Mean follow-up: 33 ± 18 months; persistent left-side paresis: n = 1; minor (non-disabling) stroke: n = 2. Post-VAD pulmonary artery: 19 ± 3.4 mmHg; P < 0.005; post-VAD pulmonary resistance: 2.2 ± 0.55 Wood units; P = 0.066. Four patients had heart transplants after a mean waiting time of 30 months after the VAD was implanted; 2 patients are still on the waiting list (waiting time: 52 and 24 months). CONCLUSIONS: Continuous flow VAD therapy is a feasible therapeutic option in adult patients with TGA and a failing systemic right ventricle as a bridge to candidacy and a bridge to a heart transplant.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gyoten T, Rojas SV, Fox H, et al. Mechanical circulatory support as a bridge to candidacy in adults with transposition of the great arteries and a systemic right ventricle. Eur J Cardiothorac Surg. 2020. PMID: 33226086. doi:10.1093/ejcts/ezaa373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。